JY231(JY231) Injection for the Treatment of Relapsed or Refractory B-Cell Leukemia
JY231(JY231) Injection for the Treatment of Relapsed or Refractory B-Cell Leukemia
Not yet recruiting · NCT06902025 · Registry updated 2025-03-30Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| JY231(JY231) Injection for the Treatment of Relapsed or Refractory B-Cell Leukemia | B-ALL | Not yet recruiting | Not applicable | 2025-03-30 | NCT06902025 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| He Huang | 12 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| The First Affiliated Hospital of Zhejiang University school of medicine | Hangzhou | China | 18 |